Regional Analysis

Global Single-use Bioprocessing Systems Market - Regional Insights

North America is expected to be the largest market for substance abuse treatment during the forecast period, accounting for over 43.7% of the market share in 2024. North America continues to dominate the global single-use bioprocessing systems market owing to the presence of large biopharmaceutical companies and growing adoption of single-use technologies in the region. The major market for single-use systems is the U.S., which is home to the majority of world's largest biopharma companies. These companies are actively investing in the development of novel biologics and biosimilars driving the need for single-use bioprocessing. Moreover, a supportive regulatory environment is also encouraging biopharma industries to incorporate single-use systems into their manufacturing operations to enhance flexibility and lower costs.
Asia Pacific is expected to be the second-largest market for single-use bioprocessing systems, accounting for over 25.2% of the market share in 2024. Asia Pacific region has emerged as the fastest growing regional market for single-use bioprocessing systems globally. Countries like China, India, South Korea and Japan are witnessing the expansion of their domestic biopharmaceutical industries at an unprecedented rate over the past decade. Local biopharma companies in Asia Pacific have ramped up investments to cater to growing healthcare demands as well as expand their international footprint. This has bolstered the sales of single-use bioprocessing equipment in the region. Additionally, the presence of global biopharmaceutical companies establishing manufacturing facilities coupled with the availability of low-cost skilled workforce makes Asia Pacific a lucrative market for suppliers of single-use systems. The growth in imports of single-use bioprocessing systems from the U.S. and Europe by Asia Pacific countries highlights the increasing adoption of flexible single-use technologies.
While North America has a strong biopharma industry base to leverage single-use systems, Asia Pacific provides immense opportunities for suppliers to tap rising investments in biomanufacturing sector and expand their geographical footprint. The pricing of single-use bioprocessing systems also varies across regions, with products available at competitive rates in Asia Pacific, helping boost its attractiveness as an emerging hotspot.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa